In the presence of L-NAME SERCA blockade induces endothelium-dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors

British Journal of Pharmacology

Volumn 137, Issue 4, 2002, Pages 545-553

  Okon, Elena B ^a   Golbabaie, Ali ^a   Van Breemen, Cornelis ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cyclopiazonic acid; Mouse aorta; Prostaglandin H2 thromboxane A2 receptor; SERCA

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATE; BRADYKININ; CALCIUM CHANNEL BLOCKING AGENT; CYCLOPIAZONIC ACID; DICHLOROBENZAMIL; DIPHENYLBORIC ACID 2 AMINOETHYL ESTER; FASUDIL; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; PHENYLEPHRINE; PROSTAGLANDIN H2; PROSTAGLANDIN RECEPTOR; RYANODINE; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; THROMBOXANE RECEPTOR;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SODIUM CALCIUM EXCHANGE; ANIMAL; AORTA; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; PHYSIOLOGY; SMOOTH MUSCLE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; AORTA; CALCIUM CHANNEL BLOCKERS; CALCIUM-TRANSPORTING ATPASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH; NG-NITROARGININE METHYL ESTER; RECEPTORS, PROSTAGLANDIN; RECEPTORS, THROMBOXANE; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; VASOCONSTRICTION;

EID: 0036797766     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704884     Document Type: Article

References (70)

1. Auch-Schwelk, W., Katusic, Z.C. & Vanhoutte, P.M. (1990). Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension, 15, 699-703.
2. Barnett, J., Chow, J., Ives, D., Chiou, M., Mackenzie, R., Osen, E., Nguyen, B., Tsing, S., Bach, C., Freire, J. et al. (1994). Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim. Biophys. Acta, 1209, 130-139.
3. Batchelor, T.J., Sadaba, J.R., Ishola, A., Pacaud, P., Munsch, C.M. & Beech, D.J. (2001). Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery. Br. J. Pharmacol., 132, 302-308.
4. Blaustein, M.P. & Lederer, W.J. (1999). Sodium/calcium exchange: Its phisiological implication. Physiological Reviews, 79, 763-854.
5. Channon, J.Y. & Leslie, C.C. (1990). A calcium-dependent mechanism for associating a soluble arachidonoyl-hydrolyzing phospholipase A2 with membrane in the macrophage cell line RAW 264.7. J. Biol. Chem., 265, 5409-5413.
6. De Nucci, G., Gryglewski, R.J., Warner, T.D. & Vane, J.R. (1988). Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc. Natl. Acad. Sci. U.S.A., 85, 2334-2338.
7. Fitzpatrick, F.A. & Soberman, R. (2001). Regulated formation of eicosanoids. J. Clin. Invest., 107, 1347-1351.
8. Fukao, M., Hattori, Y., Kanno, M., Sakuma, I. & Kitabatake, A. (1995). Thapsigargin- and cyclopiazonic acid-induced endothelium-dependent hyperpolarization in rat mesenteric artery. Br. J. Pharmacol., 115, 987-992.
9. Furchgott, R.F. & Vanhoutte, P.M. (1989). Endothelium-derived relaxing and contracting factors. FASEB J., 3, 2007-2018.
10. Furchgott, R.F. & Zawadzki, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
11. Ge, T., Hudhes, H., Junquero, D.C., Wu, K.K., Vanhoutte, P.M. & Boulanger, C.M. (1995). Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H syntase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ. Res., 76, 1003-1010.
12. 2+ channels in liver cells, and acts through a mechanism which does not involve inositol triphosphate receptors. Biochem. J., 354, 285-290.
13. Gurbel, P.A., Murugesan, S.R., Lowry, D.R. & Serebruany, V.L. (1999). Plasma thromboxane and prostacyclin are linear related and increased in patients presenting with acute myocardial infarction. Prostaglandins Leukot. Essent. Fatty Acids, 61, 7-11.
14. Hamberg, M., Svensson, J. & Samuelsson, B. (1975). Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. U.S.A., 72, 2994-2998.
15. Hathaway, C.A., Heistad, D.D., Piegors, D.J. & Miller, F.J. (2002). Regression of atherosclerosis in monkeys reduces vascular superoxide levels. Circ. Res., 90, 277-283.
16. He, G.W. & Yang, C.Q. (1999). Inhibition of vasoconstriction by the thromboxane A2 antagonist GR32191B in the human radial artery. Br. J. Clin. Pharmacol., 48, 207-215.
17. Hishinuma, T., Koseki, Y., Murai, Y., Yamazaki, T., Suzuki, K. & Mizugaki, M. (1999). Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetics. Prostaglandins Other Lipid Mediat., 58, 263-271.
18. Hoshino, Y., Morrison, K.J. & Vanhoutte, P.M. (1994). Mechanisms of hypoxic vasoconstriction in the canine isolated pulmonary artery: Role of endothelium and sodium pump. Am. J. Physiol., 267, L120-L127.
19. Houppe, J.P., Villemot, J.P., Amrein, D., Labourel, L., Clavey, M. & Mathieu, P. (1983). Early coronary spasm after myocardial revascularization surgery. Presse Med., 12, 2667-2670.
20. Kan, H., Ruan, Y. & Malik, K.U. (1996). Involvement of mitogen-activated protein kinase and translocation of cytosolic phospholipase A2 to the nuclear envelope in acetylcholine-induced prostacyclin synthesis in rabbit coronary endothelial cells. Mol. Pharmacol., 50, 1139-1147.
21. Khan, I., Sandhu, V., Misquitta, C.M. & Grover, A.K. (2000). SERCA pump isoform expression in endothelium of vein and arteries: Every endothelium is not the same. Mol. Cell. Biochem., 203, 11-15.
22. 2+ ATPase and phospholamban protein expression. Life Sci., 70, 367-379.
23. Kurowska, E.M. (2002). Nitric oxide therapies in vascular diseases. Curr. Pharm. Des., 8, 155-166.
24. Laight, D.W., Carrier, M.J. & Änggård, E.E. (1999). Endothelial cell dysfunction and pathogenesis of diabetic macroangiopathy. Diabet. Metab. Res. Rev., 15, 274-282.
25. Lasserre, B., Navarro-Delmasure, C., Pham Huu Chanh, A., Catala, J. & Hollande, E. (2000). Modifications in the TXA(2) and PGI(2) plasma levels and some other biochemical parameters during the initiation and development of non-insulin-dependent diabetes mellitus (NIDDM) syndrome in the rabbit. Prostaglandins Leukot. Essent. Fatty Acids, 62, 285-291.
26. i oscillations underlying tonic contraction in the rabbit inferior vena cava. J. Physiol., 534, 641-650.
27. Lin, P.J., Pearson, P.J. & Schaff, H.V. (1991). Endothelium-dependent contraction and relaxation of human and canine internal mammary artery: Study on bypass graft vasospasm. Surgery, 110, 127-135.
28. 2+ Influx Pathway Necessary for Coupling to Phospholipase C. J. Biol. Chem., 275, 30806-30812.
29. 2+ channels. Science, 287, 1647-1651.
30. 2+-ATPases during platelet-derived growth factor-induced smooth muscle cell proliferation. J. Biol. Chem., 267, 15808-15815.
31. Millanvoye-Van Brussel, E., David-Dufilho, M., Pham, T.D., Iouzalen, L. & Devynck, M.A. (1999). Regulation of arachidonic acid release by calcium influx in human endothelial cells. J. Vasc. Res., 36, 235-244.
32. Moncada, S. & Vane, J.R. (1979). The role of prostacyclin in vascular tissue. Fed. Proc., 38, 66-71.
33. 2+-ATPase inhibitor, cyclopiazonic acid, possibly through nitric oxide formation. Br. J. Pharmacol., 111, 655-642.
34. 2+ Transport Genes in Platelets and Endothelial Cells in Hypertension. Hypertension, 37, 135-141.
35. Mullane, K.M., Dusting, G.J., Salmon, J.A., Moncada, S. & Vane, J.R. (1979). Biotransformation and cardiovascular effects of arachidonic acid in the dog. Eur. J. Pharmacol., 54, 217-228.
36. Napoli, E. & Franco, N. (1998). Thromboxane A2 production in the pathogenesis of diabetic complications. Minerva Endocrinol., 23, 1-5.
37. 2+ influx and contraction in rat pulmonary artery. Circ. Res., 89, 923-929.
38. 2+. Circ. Res., 88, 1283-1290.
39. Oike, M., Gericke, M., Droogmans, G. & Nilius, B. (1994). Calcium entry activated by store depletion in human umbilical vein endothelial cells. Cell Calcium, 16, 367-376.
40. Ozog, A., Pouzet, B., Bobe, R. & Lompre, A.M. (1998). Characterization of the 3′ end of the mouse SERCA 3 gene and tissue distribution of mRNA spliced variants. FEBS Lett., 427, 349-352.
41. 2+-ATPases: Specific up-regulation of the 97 kDa isoform. Biochem. J., 295, 685-690.
42. 3-independent manner. Am. J. Physiol., 268, H138-H146.
43. Paul, R.J. (1998). The role of phospholamban and SERCA3 in regulation of smooth muscle-endothelial cell signalling mechanisms: Evidence from gene-ablated mice. Acta Physiol. Scand., 164, 589-597.
44. Pieper, G. (1998). Review of alteration in endothelial nitric oxide production in diabetes. Hypertension, 31, 1047-1060.
45. Rahimian, R., Van Breemen, C., Karkan, D., Dube, G. & Laher, I. (1997). Estrogen augments cyclopiazonic acid-mediated, endothelium-dependent vasodilation. Eur. J. Pharmacol., 327, 143-149.
46. Sa, G., Murugesan, G., Jaye, M., Ivashenko, Y. & Fox, P.L. (1995). Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J. Biol. Chem., 270, 2360-2366.
47. Sakurada, S., Okamoto, H., Takuwa, N., Sugimoto, N. & Takuwa, Y. (2001). Rho activation in excitatory agonist-stimulated vascular smooth muscle. Am. J. Physiol. Cell Physiol., 281, C571-C578.
48. 2+ entry in freshly isolated rabbit aortic endothelial cells. Biochem. Biophys. Res. Commun., 241, 471-475.
49. Shi, W., Hoganson, C.W., Espe, M., Bender, C.J., Babcock, G.T., Palmer, G., Kulmacz, R.J. & Tsai, A. (2000). Electron paramagnetic resonance and electron nuclear double resonance spectroscopic identification and characterization of the tyrosyl radicals in prostaglandin H synthase 1. Biochemistry, 39, 4112-4121.
50. Shimizu, K., Muramatsu, M., Kakegawa, Y., Asano, H., Toki, Y., Miyazaki, Y., Okumura, K., Hashimoto, H. & Ito, T. (1993). Role of prostaglandin H2 as an endothelium-derived contracting factor in diabetic state. Diabetes, 42, 1246-1252.
51. Shiokoshi, T., Ohsaki, Y., Kawabe, J., Fujino, T. & Kikuchi, K. (2002). Downregulation of nitric oxide accumulation by cyclooxygenase-2 induction and thromboxane A2 production in interleukin-1beta-stimulated rat aortic smooth muscle cells. J. Hypertens., 20, 455-461.
52. Shram, S.I., Lazurkina, T.YU., Myasoedov, N.F. & Varfolomeev, S.D. (1999). Enzyme self-activation is a main limitation of the preparation of eicosanoids. Enzymatic synthesis of thromboxane and 12(S)-hydroxytetraenoic acid. Appl. Biochem. Biotechnol., 82, 37-56.
53. Singh, J., Seth, S.D., Manchanda, S.C. & Seth, S. (1997). Protective actions of a thromboxane receptor antagonist, SQ 29548 on the ischemic myocardium: Morphologic and hemodynamic effects. Prostaglandins Leukot. Essent. Fatty Acids, 56, 105-110.
54. Szado, T., McLarnon, M., Wang, X. & Van Breemen, C. (2001). Role of sarcoplasmic reticulum in regulation of tonic contraction of rabbit basilar artery. Am. J. Physiol. Heart Circ. Physiol., 281, H1481-1489.
55. Taddei, S. & Vanhoutte, P.M. (1993). Endothelium-dependent contractions to endothelin in the rat aorta are mediated by thromboxane A2. J. Cardiovasc. Pharmacol., 22, S328-S331.
56. Takase, B., Maruyama, T., Kurita, A., Uehata, A., Nishioka, T., Mizuno, K., Nakamura, H., Katsura, K. & Kanda, Y. (1996). Arachidonic acid metabolites in acute myocardial infarction. Angiology, 47, 649-661.
57. Takeuchi, H., Tanabe, M., Okamoto, H. & Yamazaki, M. (1999). Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cerebral vasospasm. Neurol. Res., 21, 513-516.
58. 2+ entry channels responsible for mechanical responses of guinea-pig aorta to noradrenaline and thapsigargin using SK&F 96365 and LOE 908. Naunyn Schmiedebergs Arch. Pharmacol., 362, 160-168.
59. 2+ levels in cerebrovascular smooth muscle during chronic cerebral vasospasm. Neurol. Med. Chir. (Tokyo), 41, 238-244.
60. Tesfamariam, B., Jakubowski, J.A. & Cohen, R.A. (1989). Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TXA2. Am. J. Physiol., 257, H1327-H1333.
61. 2+ entry to contraction in rat aorta. J. Pharmacol. Exp. Ther., 285, 759-766.
62. 2+ influx via L-type and non-L-type Ca+ + channels in thromboxane A2 receptor-mediated contraction in rat aorta. J. Pharmacol. Exp. Ther., 284, 921-928.
63. Vanhoutte, P.M. (1987). Endothelium-dependent contractions in arteries and veins. Blood Vessels, 24, 141-144.
64. 2+ entry mediated by store depletion, S-nitrosylation, and TRP3 channels. Comparison of coupling and function. J. Biol. Chem., 275, 28562-28568.
65. Wiemer, G., Itter, G., Malinski, T., & Linz, W. (2001). Decreased nitric oxide availability in normotensive and hypertensive rats with failing hearts after myocardial infarction. Hypertension, 38, 1367-1371.
66. i in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol., 280, C843-C851.
67. Wu, G., Wei, C., Kulmacz, R.J., Osawa, Y. & Tsai, A.L. (1999). A mechanistic study of self-inactivation of the peroxidase activity in prostaglandin H synthase-1. J. Biol. Chem., 274, 9231-9237.
68. 2+ influx through non-specific cation channels in endothelial cells. Eur. J. Pharmacol., 251, 119-125.
69. Zheng, X.F., Guan, Y.Y. & Kwan, C.Y. (1993). Cyclopiazonic acid causes endothelium-dependent relaxation in rat aorta. Zhongguo Yao Li Xue Bao, 14, 21-26.
70. Zou, M.H. & Bachschmid, M. (1999). Hypoxia-reoxygenation triggers coronary vasospasm in isolated bovine coronary arteries via tyrosine nitration of prostacyclin synthase. J. Exp. Med., 190, 135-139.